Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals' views. 2021

Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
Department of Pediatric Haematology, Erasmus University Medical Centre - Sophia Children's Hospital, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands. M.houwing@erasmusmc.nl.

BACKGROUND In well-resourced countries, comprehensive care programs have increased life expectancy of patients with sickle cell disease, with almost all infants surviving into adulthood. However, families affected by sickle cell disease are more likely to be economically disenfranchised because of their racial or ethnic minority status. As every individual child has the right to the highest attainable standard of health under the United Nations Convention on the Rights of the Child, it is essential to identify both barriers and facilitators with regard to the delivery of adequate healthcare. Optimal healthcare accessibility will improve healthcare outcomes for children with sickle cell disease and their families. Healthcare professionals in the field of sickle cell care have first-hand experience of the barriers that patients encounter when it comes to effective care. We therefore hypothesised that these medical professionals have a clear picture of what is necessary to overcome these barriers and which facilitators will be most feasible. Therefore, this study aims to map best practises and lessons learnt in order to attain more optimal healthcare accessibility for paediatric patients with sickle cell disease and their families. METHODS Healthcare professionals working with young patients with sickle cell disease were recruited for semi-structured interviews. An interview guide was used to ensure the four healthcare accessibility dimensions were covered. The interviews were transcribed and coded. Based on field notes, initial codes were generated, to collate data (both barriers and solutions) to main themes (such as "transportation", or "telecommunication"). Through ongoing thematic analysis, definitive themes were formulated and best practices were reported as recommendations. Quotations were selected to highlight or illustrate the themes and link the reported results to the empirical data. RESULTS In 2019, 22 healthcare professionals from five different university hospitals in the Netherlands were interviewed. Participants included (paediatric) haematologists, nurses and allied health professionals. Six themes emerged, all associated with best practices on topics related to the improvement of healthcare accessibility for children with sickle cell disease and their families. Firstly, the full reimbursement of invisible costs made by caregivers. Secondly, clustering of healthcare appointments on the same day to help patients seeing all required specialists without having to visit the hospital frequently. Thirdly, organisation of care according to shared care principles to deliver specialised services as close as possible to the patient's home without compromising quality. Fourthly, optimising verbal and written communication methods with special consideration for families with language barriers, low literacy skills, or both. Fifthly, improving the use of eHealth services tailored to users' health literacy skills, including accessible mobile telephone contact between healthcare professionals and caregivers of children with sickle cell disease. Finally, increasing knowledge and interest in sickle cell disease among key stakeholders and the public to ensure that preventive and acute healthcare measures are understood and safeguarded in all settings. CONCLUSIONS This qualitative study describes the views of healthcare professionals on overcoming barriers of healthcare accessibility that arise from the intersecting vulnerabilities faced by patients with sickle cell disease and their families. The recommendations gathered in this report provide high-income countries with a practical resource to meet their obligations towards individual children under the United Nations Convention on the Rights of the Child.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008913 Minority Groups A subgroup having special characteristics within a larger group, often bound together by special ties which distinguish it from the larger group. Group, Minority,Groups, Minority,Minority Group
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003695 Delivery of Health Care The concept concerned with all aspects of providing and distributing health services to a patient population. Delivery of Dental Care,Health Care,Health Care Delivery,Health Care Systems,Community-Based Distribution,Contraceptive Distribution,Delivery of Healthcare,Dental Care Delivery,Distribution, Non-Clinical,Distribution, Nonclinical,Distributional Activities,Healthcare,Healthcare Delivery,Healthcare Systems,Non-Clinical Distribution,Nonclinical Distribution,Activities, Distributional,Activity, Distributional,Care, Health,Community Based Distribution,Community-Based Distributions,Contraceptive Distributions,Deliveries, Healthcare,Delivery, Dental Care,Delivery, Health Care,Delivery, Healthcare,Distribution, Community-Based,Distribution, Contraceptive,Distribution, Non Clinical,Distributional Activity,Distributions, Community-Based,Distributions, Contraceptive,Distributions, Non-Clinical,Distributions, Nonclinical,Health Care System,Healthcare Deliveries,Healthcare System,Non Clinical Distribution,Non-Clinical Distributions,Nonclinical Distributions,System, Health Care,System, Healthcare,Systems, Health Care,Systems, Healthcare
D005006 Ethnicity A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. Ethnic Groups,Nationality,Ethnic Group,Nationalities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000755 Anemia, Sickle Cell A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S. Hemoglobin S Disease,HbS Disease,Sickle Cell Anemia,Sickle Cell Disease,Sickle Cell Disorders,Sickling Disorder Due to Hemoglobin S,Anemias, Sickle Cell,Cell Disease, Sickle,Cell Diseases, Sickle,Cell Disorder, Sickle,Cell Disorders, Sickle,Disease, Hemoglobin S,Hemoglobin S Diseases,Sickle Cell Anemias,Sickle Cell Diseases,Sickle Cell Disorder

Related Publications

Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
May 2023, Molecular genetics & genomic medicine,
Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
April 2024, Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association,
Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
December 2019, Journal of general internal medicine,
Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
August 2023, Heliyon,
Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
December 2021, International journal of clinical pharmacy,
Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
December 2022, Vaccine: X,
Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
August 2021, BMC health services research,
Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
January 2014, Journal of clinical nursing,
Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
May 2021, European journal of cancer care,
Maite E Houwing, and Marit Buddenbaum, and Thijs C J Verheul, and Anne P J de Pagter, and Jacobus N J Philipsen, and Jan A Hazelzet, and Marjon H Cnossen
September 2022, Pediatric diabetes,
Copied contents to your clipboard!